BSEInsider Trading / SAST7 Oct 2026 · 7 Oct 2026, 10:38 am
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Archana Lonkar
iSERA Lifesciences Ltd · 534920
✦ AI SummaryPledge
iSERA Lifesciences Ltd's promoter, Archana Kakasaheb Lonkar, has submitted a disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011, regarding a change in her shareholding in the company due to the allotment of equity shares under a preferential allotment (share swap) by the board of directors on October 01, 2026.
Analysis Scores
Earnings Impact2/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
iSERA Lifesciences Ltd - 534920 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Attachments (1)
📄pdf
Download →
79C01AAA_264C_4166_92D4_78E2664C4B52_103800.pdf
View document text
October 05, 2026
To, To,
The Manager, The Board of Directors,
Listing Operations Department iSERA Lifesciences Limited
BSE Limited 301, Samath Aishwarya, Opp. Medipoint
P.J. Towers, Dalal Street, Hospital,
Off New DP Road, Aundh,
Mumbai -400 001
Pune– 4110 07, Maharashtra
Sub: Disclosure pursuant to Regulation 29(2) of the SEBI (Substantial Acquisition of Shares
and Takeovers) Regulations, 2011.
SCRIP CODE: 534920
ISIN: INE899M0 1020
Dear SirMadam,
This is to inform that I, Archana Kakasaheb Lonkar, Promoter of iSERA Lifesciences
Limited ("Target Company") resident of 1301 Apollonia, Triveni Laurel, Near Birla School,
Kalyan (W), Beside R.T.O Kalyan-421301, hereby submit the disclosure with regard to the
change in my shareholding in the Target Company arising pursuant to the allotment of Equity
Shares to me under Preferential Allotment (Share Swap) by the Board of Directors of the Target
Company at its meeting held on October 01, 2026.
With reference to the aforementioned subject, please find enclosed herewith the disclosure as
per Regulation 29(2)o f SEBI (Substantial Acquisition of Shares and Takeovers) Regulations,
2011.
This is for your information and record.
Yours truly,
Archana Kakasaheb Lonkar
Promoter
Format for disclosures under Regulation 2\2) of SE.BI (Substantial Acquisition of Shares and
Takeovers) Regulations, 2011
Name of the Target (ompany(T) iSERA Lifesciences Limited ("TC")
Office No. Al-1202, 12th Floor, Boulevard
Tower, Phase-2, CTS No. 11, Sadhu Vaswani
Chowk, Camp, Pune - 411001
Name(s) of the acquirer and Persons Archana Kakasaheb Lonkar
Concert (PAC) with the PAN: AVLPK8551G
Acting
acquirer
Whether the acquirer belongs to Yes, the Acquirer is a Promoter of the TC
Promoter/P romoter group
Name(s)of the StockExchange(s) where the BSE Limited (Scrip Code: 534920)
shares of TC are Listed
Details of the acquisition / disposal as follows Number % %w.r.t. total
W.r.t.totalshare diluted
ivoting capital share/voting
capitalof the
wherever
applicable(*) TC(**)
Before the acquisition under
consideration, bolding of:
a) Shares carrying voting rights 7,00,000 8.32% 8.32%
b} Shares in the nature ef eneumbranee
(pledge iea non dispesal undertaking
ethers)
e) Votig rights fVR} otherwise than by
sheres
d) Werrentseenvertibleseeurties/any ether
instrament that entittes-the sequirer te
Feeeve-sheres-earryng vetng ights in-the
Tetspeeify helding in-eaeh eategery)
e) Total (atbtctd)
7,00,000 8.32% 8.32%
Details of acquisition/sale
a) Shares carrying voting rights acquired 4,95,000 2.01% 2.01%
seld
b) VRs aequired tseld otherwise-than by
sheres
e) Warants/eenvertibleseeuritiestanyother
instrment thet entittes-the- eequtrerte
Feeeive shereS earrying voting ights-in the
Te fspeeify holding-i-eaeh-eategery)
aequiredseld
d) Sheres enetmbered finvekedtreleased by
the-aeeirer
4,95,000 2.01% 2.01%
e) Total(atbtct/-d)
After the acquisition /sale, holding of:
a) Shares canying voting rights
acquired 11,95,000 4.86% 4.86%
b) Sheres eneHmbered witlh- the
aeqrer
) VRsetherwisethanbyshares
d Warants eeRVertibłe seeurities any
ether instrument that entitles the-aeqirer
te-receive shares-earrying vəting rights-in
the Te topeeify hełding in eaeh eategory)
afteraequisitiOR
e) Total(atbtc+d)
11,95,000 4.86% 4.86%
Mode of acquisition/sale (e.g. open market/off- Preferential Allotment (Share Swap) pursuant to
marketpublic issuc/rights issue / preferential the allotment of Equity Shares by the Board of
allotment /inter-se transfer ctc). Directors of the Target Company at its meeting
held on October 01, 2026
Date of acquisition/saleefsheres/VR or date of October 01, 2026
receipt of intimation of allotment of shares,
whichever is applicable
Equity share capitaltotal voting capital of the Equity Capital Rs. 8,40,89,720/
TCb efore the said acquisition /sałe
84,08,972 Equity Shares of Rs. 10/-cach
Equity share capital/total voting capital Equity Capital Rs. 24,59, 17,720/
of the TC after the said acquisition/sałe
2,45,91,772 Equity Shares of Rs. 100-cach
Equity Capital Rs. 24,59,17,720/
Total diluted share/voting capital of the TC
after the said acquisition
2,45,91,772 Equity Shares of Rs. l0/-cach
() Total share capital/ voting capital to be taken as per the latest filing done by the company to the
Stock Exchange under Clause 35 of the listing Agreement.
(**) Diluted share/ voting capital means the total number of shares in the TC assuming full conversion
of the outstanding convertible securities/warrants into equity shares of the TC.
Archana Kakasaheb Lonkar
Promoter
Date: October 05, 2026
*****